Klingenstein Fields & Co. LP Has $6.16 Million Position in The Procter & Gamble Company (NYSE:PG)

Klingenstein Fields & Co. LP cut its position in The Procter & Gamble Company (NYSE:PG) by 1.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 42,066 shares of the company’s stock after selling 461 shares during the quarter. Klingenstein Fields & Co. LP’s holdings in Procter & Gamble were worth $6,164,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Geode Capital Management LLC increased its position in Procter & Gamble by 1.1% in the 1st quarter. Geode Capital Management LLC now owns 46,754,131 shares of the company’s stock valued at $6,936,343,000 after acquiring an additional 510,559 shares during the period. Morgan Stanley increased its position in Procter & Gamble by 12.6% in the 4th quarter. Morgan Stanley now owns 44,320,700 shares of the company’s stock valued at $6,717,246,000 after acquiring an additional 4,959,527 shares during the period. Moneta Group Investment Advisors LLC increased its position in Procter & Gamble by 96,526.4% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 38,535,557 shares of the company’s stock valued at $5,840,449,000 after acquiring an additional 38,495,676 shares during the period. Wellington Management Group LLP increased its position in Procter & Gamble by 9.4% in the 3rd quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company’s stock valued at $5,193,916,000 after acquiring an additional 3,047,557 shares during the period. Finally, Northern Trust Corp increased its position in Procter & Gamble by 2.3% in the 3rd quarter. Northern Trust Corp now owns 29,313,150 shares of the company’s stock valued at $4,275,616,000 after acquiring an additional 670,862 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have issued reports on PG. UBS Group upped their price target on shares of Procter & Gamble from $172.00 to $178.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Wells Fargo & Company upped their price target on shares of Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a research report on Wednesday, January 24th. Raymond James upped their price objective on shares of Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a research note on Wednesday, January 24th. Barclays upped their price objective on shares of Procter & Gamble from $165.00 to $168.00 and gave the company an “overweight” rating in a research note on Friday, April 12th. Finally, StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Seven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $168.53.

Procter & Gamble Stock Up 0.5 %

NYSE PG traded up $0.85 on Friday, hitting $158.14. 12,034,186 shares of the company were exchanged, compared to its average volume of 6,329,782. The company has a market cap of $372.11 billion, a PE ratio of 25.84, a PEG ratio of 3.23 and a beta of 0.44. The Procter & Gamble Company has a 12 month low of $141.45 and a 12 month high of $163.14. The stock has a fifty day moving average of $159.14 and a 200-day moving average of $152.97. The company has a current ratio of 0.64, a quick ratio of 0.44 and a debt-to-equity ratio of 0.48.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a net margin of 17.60% and a return on equity of 34.04%. The firm had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. During the same period last year, the firm earned $1.37 earnings per share. The business’s quarterly revenue was up .6% compared to the same quarter last year. As a group, analysts forecast that The Procter & Gamble Company will post 6.53 earnings per share for the current year.

Procter & Gamble Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.55%. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date of this dividend is Thursday, April 18th. Procter & Gamble’s dividend payout ratio (DPR) is 65.85%.

Insider Buying and Selling at Procter & Gamble

In other news, insider Marc S. Pritchard sold 101,704 shares of the stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $153.57, for a total value of $15,618,683.28. Following the completion of the sale, the insider now owns 163,428 shares in the company, valued at $25,097,637.96. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, insider Marc S. Pritchard sold 101,704 shares of the stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $153.57, for a total value of $15,618,683.28. Following the completion of the sale, the insider now owns 163,428 shares in the company, valued at $25,097,637.96. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Ma. Fatima Francisco sold 74,443 shares of the stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $153.30, for a total transaction of $11,412,111.90. Following the completion of the sale, the chief executive officer now owns 973 shares of the company’s stock, valued at approximately $149,160.90. The disclosure for this sale can be found here. Over the last three months, insiders have sold 279,063 shares of company stock valued at $43,187,745. Corporate insiders own 0.17% of the company’s stock.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.